Page last updated: 2024-11-07

spironolactone and Carcinoma, Small Cell

spironolactone has been researched along with Carcinoma, Small Cell in 1 studies

Spironolactone: A potassium sparing diuretic that acts by antagonism of aldosterone in the distal renal tubules. It is used mainly in the treatment of refractory edema in patients with congestive heart failure, nephrotic syndrome, or hepatic cirrhosis. Its effects on the endocrine system are utilized in the treatments of hirsutism and acne but they can lead to adverse effects. (From Martindale, The Extra Pharmacopoeia, 30th ed, p827)
spironolactone : A steroid lactone that is 17alpha-pregn-4-ene-21,17-carbolactone substituted by an oxo group at position 3 and an alpha-acetylsulfanyl group at position 7.

Carcinoma, Small Cell: An anaplastic, highly malignant, and usually bronchogenic carcinoma composed of small ovoid cells with scanty neoplasm. It is characterized by a dominant, deeply basophilic nucleus, and absent or indistinct nucleoli. (From Stedman, 25th ed; Holland et al., Cancer Medicine, 3d ed, p1286-7)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Merino Angulo, J1
Bilbao Ercoreca, F1
del Villar Negro, A1
de la Riva Aguinaco, C1
Aguirre Errasti, C1

Other Studies

1 other study available for spironolactone and Carcinoma, Small Cell

ArticleYear
[Bilateral metastatic gynecomastia. An unusual manifestation of small-cell pulmonary carcinoma].
    Revista clinica espanola, 1983, Jan-15, Volume: 168, Issue:1

    Topics: Breast Neoplasms; Carcinoma, Small Cell; Gynecomastia; Humans; Liver Cirrhosis, Alcoholic; Lung Neop

1983